Conditions
HomeMore KnowledgeConditionsBenign prostatic hyperplasia (BPH)
Print Next

Benign prostatic hyperplasia (BPH)

Tamsulosin is produced as 0.4mg Extended release Capsule by Shahredaru pharmaceutical company. Tamsulosin is an alpha-blocker that relaxes the muscles in the prostate and bladder neck, making it easier to urinate. Tamsulosin is used to improve urination in men with benign prostatic hyperplasia (enlarged prostate).
What is BPH?
Benign prostatic hyperplasia (BPH) is a common urological condition caused by the non-cancerous enlargement of the prostate gland as men get older. Prostate problems are common in men 50 and older.


Risk factors

Risk factors for prostate gland enlargement include:
Race
Family history: Having a blood relative, such as a father or brother, with prostate problems means you're more likely to have problems.

Aging and Dihydrotestosterone (DHT) are the two best-stablished causes required for the developement of BPH. In men castrated prior to puberty, BPH does not develop and regression of BPH and improvement in urinary symptoms has been reported following castration.

Throughout their lives, men produce testosterone, a male hormone, and small amounts of estrogen, a female hormone. As men age, the amount of active testosterone in their blood decreases, which leaves a higher proportion of estrogen. Scientific studies have suggested that benign prostatic hyperplasia may occur because the higher proportion of estrogen within the prostate increases the activity of substances that promote prostate cell growth.

BPH (benign prostatic hyperplasia) is a natural consequence of aging and is more likely to occur in men whose fathers or brothers experienced prostate enlargement.

What are the symptoms of benign prostatic hyperplasia?

Obstructive Symptoms
Hesitancy: You may have to wait at the toilet for a while before urine starts to flow.
Dribbling after urination ends
A sensation of incomplete emptying of the bladder even after passing urine
Weak flow of urine
Straining in order to urinate

Irritative Symptoms
Frequency (You may pass urine more often than normal)
Urgency (You may have to get to the toilet quickly)
Nocturia (frequent urination during periods of sleep)


How is benign prostatic hyperplasia treated?

The three main treatments are:

Watchful Waiting
Medications
Surgery

Medications
Alpha blockers: Commonly prescribed alpha blockers include:
terazosin
doxazosin
tamsulosin
alfuzosin
prazosin

5-alpha reductase inhibitors:
finasteride
dutasteride

Combination medications: Your doctor might recommend taking combining an alpha-blocker with a testosterone blocker may work better than either drug alone, such as:
finasteride and doxazosin

Surgery
There are several types of surgical therapy. Surgical therapy might be recommended if you have:
Recurrent urinary tract infections
Bladder stones
recurrent gross haematuria
renal insufficiency
Acute urinary retention
large bladder diverticulum

The introduction of drug A patient Pathogens Symptoms Diagnosis and treatment
 (visite count : 1072)
Date: 10/16/2016
Source: Risk factors

Risk factors for prostate gland enlargement include:
Race
Family history: Having a blood relative, such as a father or brother, with prostate problems means you're more likely to have problems.

Aging and Dihydrotestosterone (DHT) are the two best-stablished causes required for the developement of BPH. In men castrated prior to puberty, BPH does not develop and regression of BPH and improvement in urinary symptoms has been reported following castration.

Throughout their lives, men produce testosterone, a male hormone, and small amounts of estrogen, a female hormone. As men age, the amount of active testosterone in their blood decreases, which leaves a higher proportion of estrogen. Scientific studies have suggested that benign prostatic hyperplasia may occur because the higher proportion of estrogen within the prostate increases the activity of substances that promote prostate cell growth.

BPH (benign prostatic hyperplasia) is a natural consequence of aging and is more likely to occur in men whose fathers or brothers experienced prostate enlargement.